Skip to main content
Equibles
CRDF logo

CRDF · Cardiff Oncology, Inc. · Short Interest

Track CRDF — free

Use CRDF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRDF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.12 -0.06 (-5.08%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 11, 2026
Market Cap
$95.30M
Shares
77.80M
Volume · Oct 2 628.34K Avg daily vol (3M) 1.08M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

CRDF Latest Reported Short Interest

FINRA reported 12,308,314 CRDF shares sold short as of the September 15, 2026 settlement date, an increase of 623,689 shares. Days to cover was 12.06 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CRDF Short Interest Forecast

Equibles' model estimates 12,314,548 shares sold short for the September 30, 2026 settlement, +0.1% versus the latest reported position, with a likely range of 11,222,291 to 13,473,311 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 Low confidence 60% chance it falls
12,314,548 +0.1% vs reported
Likely range 11,222,291 to 13,473,311 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
86/100
Short interest 15.8% of shares — P96 Days to cover 12.1 — P92 Price vs VWAP +8.1% — P90 Short-volume trend +7.6% — P75 Short interest change +5.3% — P63 Worst FTD 0.05% of shares — P76

Positioning score 85.6 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-04 20:11 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-10-15 Scheduled
    FINRA publishes Oct 26
    		 — — — —
    2026-09-30 Scheduled
    FINRA publishes Oct 9
    		 — — — —
    2026-09-15 12,308,314 11,684,625 +623,689 12.06
    2026-08-31 11,684,625 11,896,392 -211,767 18.16
    2026-08-14 11,896,392 12,193,957 -297,565 15.27
    2026-07-31 12,193,957 12,086,690 +107,267 9.26
    2026-07-15 12,086,690 12,814,192 -727,502 6.16
    2026-06-30 12,814,192 16,146,684 -3,332,492 7.76
    2026-06-15 16,146,684 18,129,306 -1,982,622 7.96
    2026-05-29 18,129,306 18,017,949 +111,357 12.28
    2026-05-15 18,017,949 18,374,168 -356,219 26.88
    2026-04-30 18,374,168 18,322,268 +51,900 29.02
    2026-04-15 18,322,268 17,918,024 +404,244 22.21
    2026-03-31 17,918,024 17,416,560 +501,464 32.33
    2026-03-13 17,416,560 17,680,285 -263,725 27.04
    2026-02-27 17,680,285 17,980,619 -300,334 23.46
    2026-02-13 17,980,619 17,189,706 +790,913 21.31
    2026-01-30 17,189,706 16,211,328 +978,378 6.35
    2026-01-15 16,211,328 15,654,534 +556,794 17.48
    2025-12-31 15,654,534 16,135,704 -481,170 14.39
    2025-12-15 16,135,704 15,589,278 +546,426 15.65
    2025-11-28 15,589,278 14,824,309 +764,969 19.71
    2025-11-14 14,824,309 14,251,146 +573,163 21.46
    2025-10-31 14,251,146 14,261,774 -10,628 18.76
    2025-10-15 14,261,774 15,176,750 -914,976 15.19

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1213037 CUSIP 14147L108 13F (30d) 3 filings 3 filers Visit website Investor relations